Keywords: USA, FDA, Bristol-Myers Squibb, Otsuka, Abilify, Pfizer, Geodon, Revatio

US FDA clears new indications for B-MS/Otsuka’s Abilify and Pfizer’s Geodon

Article | 23 November 2009

Print This

Ahead of the weekend, the US Food and Drug Administration cleared additional indications for currently-marketed drugs from US drug majors ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in